General Information of Drug (ID: DMZCPAQ)

Drug Name
1-(10H-phenothiazin-10-yl)-3-phenylbutan-1-one
Synonyms CHEMBL240262; 1-(10H-phenothiazin-10-yl)-3-phenylbutan-1-one
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 345.5
Logarithm of the Partition Coefficient (xlogp) 5.2
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C22H19NOS
IUPAC Name
1-phenothiazin-10-yl-3-phenylbutan-1-one
Canonical SMILES
CC(CC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31)C4=CC=CC=C4
InChI
InChI=1S/C22H19NOS/c1-16(17-9-3-2-4-10-17)15-22(24)23-18-11-5-7-13-20(18)25-21-14-8-6-12-19(21)23/h2-14,16H,15H2,1H3
InChIKey
WFXGFQNNLYOETN-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44435197
ChEBI ID
CHEMBL240262
TTD ID
D06YEB
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cholinesterase (BCHE) TTEB0GD CHLE_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78.